Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-013395
Filing Date
2020-11-09
Accepted
2020-11-09 16:41:59
Documents
66
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vygr-20200930x10q.htm   iXBRL 10-Q 2615436
2 EX-10.1 vygr-20200930xex10d1.htm EX-10.1 22427
3 EX-31.1 vygr-20200930xex31d1.htm EX-31.1 13719
4 EX-31.2 vygr-20200930xex31d2.htm EX-31.2 13812
5 EX-32.1 vygr-20200930xex32d1.htm EX-32.1 10730
6 GRAPHIC vygr-20200930x10q006.jpg GRAPHIC 60152
  Complete submission text file 0001558370-20-013395.txt   9051676

Data Files

Seq Description Document Type Size
7 EX-101.SCH vygr-20200930.xsd EX-101.SCH 63687
8 EX-101.CAL vygr-20200930_cal.xml EX-101.CAL 55161
9 EX-101.DEF vygr-20200930_def.xml EX-101.DEF 229651
10 EX-101.LAB vygr-20200930_lab.xml EX-101.LAB 491071
11 EX-101.PRE vygr-20200930_pre.xml EX-101.PRE 396494
12 EXTRACTED XBRL INSTANCE DOCUMENT vygr-20200930x10q_htm.xml XML 1593381
Mailing Address 75 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 75 SIDNEY STREET CAMBRIDGE MA 02139 857-259-5340
Voyager Therapeutics, Inc. (Filer) CIK: 0001640266 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37625 | Film No.: 201298319
SIC: 2836 Biological Products, (No Diagnostic Substances)